Travere Therapeutics, Inc. · NASDAQ:TVTX
Cline Christopher R. sold 2,491 Travere Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 6, 2026 · Filed May 6, 2026
From May 4 to May 6, 2026, Cline Christopher R. (CHIEF FINANCIAL OFFICER) sold 2,491 Travere Therapeutics, Inc. shares at an average US$46.31 for US$115K under a trading plan, leaving 118,658 shares. Filed May 6, 2026 (Form 4).
- Sold
- 2,491 shares
- Price
- US$46.31 average (US$43.95 to US$46.65)
- Value
- US$115K
- Holding after
- 118,658 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 4,250 | 121,149 | Direct | |
| May 5, 2026 | Common Stock | Sale | 2,181 | US$46.65 | 118,968 | Direct |
| May 6, 2026 | Common Stock | Sale | 310 | US$43.95 | 118,658 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Cline Christopher R.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Cline Christopher R. · Sep 17, 2026
- Form 4 · Cline Christopher R. · Sep 3, 2026
- Form 4 · Cline Christopher R. · Apr 15, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026